Patent Assignment
Reel/Frame 067483/0848
Change of Name
Recorded: 2024-05-21
Pages: 4
Assignor
EBRIS PHARMA CO.
Executed: 2024-04-01
Assignee
INTERLUDE BIOPHARMA CO.
1450 BRICKELL AVE., MIAMI, FLORIDA, 33131
Covered Property
(1)
Treatment of Cancer with Larazotide Derivatives in Combination with Immune Checkpoint Inhibitors
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 26, 2021
From: MADAN, JAY
To: 9 METERS BIOPHARMA, INC.
Reel/Frame 056359/0858 →
Assignment of Assignor's Interest
May 26, 2021
From: LAUMAS, SANDEEP
To: INNOVATE BIOPHARMACEUTICALS, INC.
Reel/Frame 056359/0869 →
Change of Name
May 26, 2021
From: INNOVATE BIOPHARMACEUTICALS, INC.
To: 9 METERS BIOPHARMA, INC.
Reel/Frame 056396/0451 →
Intellectual Property Security Agreement
Apr 10, 2023
From: 9 METERS BIOPHARMA, INC.; NAIA RARE DISEASES, LLC
To: HIGH TRAIL SPECIAL SITUATIONS LLC
Reel/Frame 063281/0653 →
Asset Purchase Agreement
May 21, 2024
From: 9 METERS BIOPHARMA, INC.
To: EBRIS PHARMA CO.
Reel/Frame 068481/0001 →